Artivion (AORT) FCF Margin (2010 - 2026)
Artivion posted quarterly FCF Margin of 5.89% for Q1 2026, up 1492.0% year-on-year from 0.37% in Q1 2025, and up 14.07% on a QoQ basis from 6.85% in Q4 2025.
Artivion (AORT) has 17 years of FCF Margin data on file, last reported at 5.89% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 1492.0% year-over-year to 5.89%; the trailing twelve-month figure through Mar 2026 stood at 3.18% (up 329.0% YoY), and the FY2025 full-year result was 0.19%, down 265.0% from the prior year.
- FCF Margin for Q1 2026 stood at 5.89%, up from 6.85% in the prior quarter.
- Across five years, FCF Margin topped out at 15.57% in Q3 2025 and bottomed at 20.8% in Q1 2025.
- The 5-year median for FCF Margin is 1.44% (2022), against an average of 0.41%.
- The widest annual swing landed in 2023, when FCF Margin surged 1792 bps; it then tumbled 1581 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 5.05% in 2022, then jumped by 273 bps to 8.72% in 2023, then climbed by 3 bps to 8.96% in 2024, then tumbled by 177 bps to 6.85% in 2025, then grew by 14 bps to 5.89% in 2026.
- The last three FCF Margin figures came in at 5.89% (Q1 2026), 6.85% (Q4 2025), and 15.57% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn | -5.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.89% |
| Dec 31, 2025 | -6.85% |
| Sep 30, 2025 | 15.57% |
| Jun 30, 2025 | 10.38% |
| Mar 31, 2025 | -20.80% |
| Dec 31, 2024 | 8.96% |
| Sep 30, 2024 | 8.16% |
| Jun 30, 2024 | 3.70% |
| Mar 31, 2024 | -9.34% |
| Dec 31, 2023 | 8.72% |
| Sep 30, 2023 | 5.88% |
| Jun 30, 2023 | 5.31% |
| Mar 31, 2023 | -10.81% |
| Dec 31, 2022 | -5.05% |
| Sep 30, 2022 | 1.44% |
| Jun 30, 2022 | -12.61% |
| Mar 31, 2022 | -3.67% |
| Dec 31, 2021 | -2.33% |
| Sep 30, 2021 | -8.56% |
| Jun 30, 2021 | -4.07% |
| Mar 31, 2021 | -6.39% |
| Dec 31, 2020 | 4.85% |
| Sep 30, 2020 | 9.65% |
| Jun 30, 2020 | -8.61% |
| Mar 31, 2020 | 0.14% |
| Dec 31, 2019 | -2.57% |
| Sep 30, 2019 | 16.18% |
| Jun 30, 2019 | -1.97% |
| Mar 31, 2019 | -0.05% |
| Dec 31, 2018 | 13.29% |
| Sep 30, 2018 | 11.45% |
| Jun 30, 2018 | -0.69% |
| Mar 31, 2018 | -19.12% |
| Dec 31, 2017 | 8.95% |
| Sep 30, 2017 | 3.99% |
| Jun 30, 2017 | -8.67% |
| Mar 31, 2017 | 4.07% |
| Dec 31, 2016 | 5.24% |
| Sep 30, 2016 | 15.32% |
| Jun 30, 2016 | 7.73% |
| Mar 31, 2016 | 1.37% |
| Dec 31, 2015 | 2.79% |
| Sep 30, 2015 | 10.46% |
| Jun 30, 2015 | 7.77% |
| Mar 31, 2015 | 0.72% |
| Dec 31, 2014 | 9.96% |
| Sep 30, 2014 | 4.18% |
| Jun 30, 2014 | 4.70% |
| Mar 31, 2014 | -8.61% |
| Dec 31, 2013 | 12.32% |
| Sep 30, 2013 | 17.35% |
| Jun 30, 2013 | 11.74% |
| Mar 31, 2013 | -6.07% |
| Dec 31, 2012 | 21.71% |
| Sep 30, 2012 | 16.21% |
| Jun 30, 2012 | 6.85% |
| Mar 31, 2012 | 3.42% |
| Dec 31, 2011 | 8.22% |
| Sep 30, 2011 | 16.89% |
| Jun 30, 2011 | 10.60% |
| Mar 31, 2011 | 11.90% |
| Dec 31, 2010 | 21.80% |
| Sep 30, 2010 | 11.03% |